Transaction Overview On February 20, 2025, Whitefort Capital Management, LP (Trades, Portfolio) executed a strategic stock transaction involving Arbutus Biophar
If PH-ILD studies translate into the real world, the market opportunity for Liquidia is enormous. Where should we expect LQDA stock to be in the next few months? Find out.
Liquidia Corporation's litigation battle and upcoming commercial launch of its primary candidate, YUTREPIA, take spotlight. Click to read why LQDA is a Hold.
Liquidia Technologies (LQDA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The mean of analysts' price targets for Liquidia Technologies (LQDA) points to a 132.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The consensus price target hints at a 126.1% upside potential for Liquidia Technologies (LQDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are...
The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally,...
U.S. stocks were lower, with the Dow Jones index falling over 1% on Wednesday.
Shares of Petco Health and Wellness Company, Inc. WOOF rose sharply during Wedne...
Shares of Nikola Corporation NKLA fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a m...
U.S. stock futures were slightly higher this morning, with the S&P 500 futures gaining around 0.1% on Monday.
Shares of Liquidia Corporation LQDA fell sharply ...
Loading... Loading...
Shares of Science Applications International Corporation SAIC declined 11% to $119.91 following first-quarter results.
SAIC reported a 9...
The dynamics of the cluster headache market are anticipated to change during the forecast period (2023–2032) owing to the rising prevalence of cluster...